LIFEVANTAGE CORP Revenue Breakdown
No Revenue Breakdown for LFVN on this site yet.
- 2026-06-30: Others Not split by product in the filing$182.59M100.00%; Total revenue $182.59M.
- 2025-06-30: Others Not split by product in the filing$228.53M100.00%; Total revenue $228.53M.
- 2024-06-30: Others Not split by product in the filing$200.16M100.00%; Total revenue $200.16M.
- 2023-06-30: Others Not split by product in the filing$213.40M100.00%; Total revenue $213.40M.
Source checked: the stored Revenue Breakdown page for LFVN.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product in the filing $182.59M 100.00% | $182.59M |
| 2025-06-30 | Not split by product in the filing $228.53M 100.00% | $228.53M |
| 2024-06-30 | Not split by product in the filing $200.16M 100.00% | $200.16M |
| 2023-06-30 | Not split by product in the filing $213.40M 100.00% | $213.40M |
| 2022-06-30 | Not split by product in the filing $206.36M 100.00% | $206.36M |
| 2021-06-30 | Not split by product in the filing $220.18M 100.00% | $220.18M |
| 2020-06-30 | Not split by product in the filing $232.91M 100.00% | $232.91M |
| 2019-06-30 | Not split by product in the filing $225.96M 100.00% | $225.96M |
| 2018-06-30 | Not split by product in the filing $203.20M 100.00% | $203.20M |
| 2017-06-30 | Not split by product in the filing $199.49M 100.00% | $199.49M |
| 2016-06-30 | Not split by product in the filing $206.54M 100.00% | $206.54M |
| 2015-06-30 | Not split by product in the filing $190.34M 100.00% | $190.34M |
| 2014-06-30 | Not split by product in the filing $213.97M 100.00% | $213.97M |
| 2013-06-30 | Not split by product in the filing $208.18M 100.00% | $208.18M |
| 2012-06-30 | Not split by product in the filing $126.18M 100.00% | $126.18M |
| 2011-06-30 | Not split by product in the filing $38.92M 100.00% | $38.92M |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $42.38M 100.00% | $42.38M |
| 2026-03-31 | Not split by product $43.72M 100.00% | $43.72M |
| 2025-12-31 | Not split by product $48.93M 100.00% | $48.93M |
| 2025-09-30 | Not split by product $47.56M 100.00% | $47.56M |
| 2025-06-30 | Not split by product $55.11M 100.00% | $55.11M |
| 2025-03-31 | Not split by product $58.44M 100.00% | $58.44M |
| 2024-12-31 | Not split by product $67.76M 100.00% | $67.76M |
| 2024-09-30 | Not split by product $47.21M 100.00% | $47.21M |
| 2024-06-30 | Not split by product $48.93M 100.00% | $48.93M |
| 2024-03-31 | Not split by product $48.24M 100.00% | $48.24M |
| 2023-12-31 | Not split by product $51.62M 100.00% | $51.62M |
| 2023-09-30 | Not split by product $51.36M 100.00% | $51.36M |
| 2023-06-30 | Not split by product $54.22M 100.00% | $54.22M |
| 2023-03-31 | Not split by product $53.74M 100.00% | $53.74M |
| 2022-12-31 | Not split by product $53.66M 100.00% | $53.66M |
| 2022-09-30 | Not split by product $51.77M 100.00% | $51.77M |
| 2022-06-30 | Not split by product $50.94M 100.00% | $50.94M |
| 2022-03-31 | Not split by product $50.00M 100.00% | $50.00M |
| 2021-12-31 | Not split by product $52.19M 100.00% | $52.19M |
| 2021-09-30 | Not split by product $53.22M 100.00% | $53.22M |
| 2021-06-30 | Not split by product $54.78M 100.00% | $54.78M |
| 2021-03-31 | Not split by product $51.57M 100.00% | $51.57M |
| 2020-12-31 | Not split by product $59.01M 100.00% | $59.01M |
| 2020-09-30 | Not split by product $54.83M 100.00% | $54.83M |
| 2020-06-30 | Not split by product $59.37M 100.00% | $59.37M |
| 2020-03-31 | Not split by product $56.08M 100.00% | $56.08M |
| 2019-12-31 | Not split by product $61.24M 100.00% | $61.24M |
| 2019-09-30 | Not split by product $56.23M 100.00% | $56.23M |
| 2019-06-30 | Not split by product $56.17M 100.00% | $56.17M |
| 2019-03-31 | Not split by product $56.01M 100.00% | $56.01M |
| 2018-12-31 | Not split by product $58.17M 100.00% | $58.17M |
| 2018-09-30 | Not split by product $55.61M 100.00% | $55.61M |
| 2018-06-30 | Not split by product $54.03M 100.00% | $54.03M |
| 2018-03-31 | Not split by product $50.56M 100.00% | $50.56M |
| 2017-12-31 | Not split by product $49.48M 100.00% | $49.48M |
| 2017-09-30 | Not split by product $49.13M 100.00% | $49.13M |
| 2017-06-30 | Not split by product $50.64M 100.00% | $50.64M |
| 2017-03-31 | Not split by product $45.01M 100.00% | $45.01M |
| 2016-12-31 | Not split by product $48.95M 100.00% | $48.95M |
| 2016-09-30 | Not split by product $54.89M 100.00% | $54.89M |
| 2016-06-30 | Not split by product $53.03M 100.00% | $53.03M |
| 2016-03-31 | Not split by product $56.16M 100.00% | $56.16M |
| 2015-12-31 | Not split by product $51.99M 100.00% | $51.99M |
| 2015-09-30 | Not split by product $45.35M 100.00% | $45.35M |
| 2015-06-30 | Not split by product $45.30M 100.00% | $45.30M |
| 2015-03-31 | Not split by product $45.16M 100.00% | $45.16M |
| 2014-12-31 | Not split by product $48.25M 100.00% | $48.25M |
| 2014-09-30 | Not split by product $51.63M 100.00% | $51.63M |
| 2014-06-30 | Not split by product $56.04M 100.00% | $56.04M |
| 2014-03-31 | Not split by product $55.06M 100.00% | $55.06M |
| 2013-12-31 | Not split by product $51.54M 100.00% | $51.54M |
| 2013-09-30 | Not split by product $51.33M 100.00% | $51.33M |
| 2013-06-30 | Not split by product $51.51M 100.00% | $51.51M |
| 2013-03-31 | Not split by product $50.37M 100.00% | $50.37M |
| 2012-12-31 | Not split by product $53.44M 100.00% | $53.44M |
| 2012-09-30 | Not split by product $52.86M 100.00% | $52.86M |
| 2012-06-30 | Not split by product $44.60M 100.00% | $44.60M |
| 2012-03-31 | Not split by product $36.21M 100.00% | $36.21M |
| 2011-12-31 | Not split by product $25.28M 100.00% | $25.28M |
| 2011-09-30 | Not split by product $20.08M 100.00% | $20.08M |
| 2011-06-30 | Not split by product $15.04M 100.00% | $15.04M |
| 2011-03-31 | Not split by product $9.97M 100.00% | $9.97M |
| 2010-12-31 | Not split by product $7.46M 100.00% | $7.46M |
| 2010-09-30 | Not split by product $6.44M 100.00% | $6.44M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |